Wet AMD
10 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD (NCT04704921) | AbbVie | 2020-12-29 |
| Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV) (NCT01339949) | Oraya Therapeutics, Inc. | 2011-06-01 |
| Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy (NCT01310686) | West Coast Retina Medical Group, Inc. | 2011-04-01 |
| INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD (NCT01016873) | Oraya Therapeutics, Inc. | 2009-11-01 |
| Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis (NCT00804934) | Retina Institute of Hawaii | 2008-02-01 |
| Intravitreal Bevacizumab for Retinal Disorders (NCT00403026) | Narayana Nethralaya | 2006-08-01 |
Track Wet AMD automatically
Every clearance here is in the API, with alerts when new ones post.